What is dactinomycin actinomycin D used to treat?

Dactinomycin, also known as actinomycin D, is a chemotherapy medication used to treat a number of types of cancer. This includes Wilms tumor, rhabdomyosarcoma, Ewing’s sarcoma, trophoblastic neoplasm, testicular cancer, and certain types of ovarian cancer. It is given by injection into a vein.

What class of drug is actinomycin?

In some cases, health care professionals may use the trade name Cosmegen or other name Actinomycin-D when referring to the generic drug name dactinomycin. Drug type: Dactinomycin is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.

Is actinomycin A antibiotic?

Actinomycin D is a well-known antibiotic that exhibits high antibacterial and antitumor activity. It has been widely used in clinical practice since 1954 as an anticancer drug to treat many tumors, such as Wilms and Ewing tumors, testicular cancer, sarcomas, and choriocarcinoma.

Is dactinomycin FDA approved?

3/13/2009: (earliest label available on Drugs@FDA) Approved as part of a combination chemotherapy and/or multi-modality treatment regimen for the treatment of Wilms tumor, childhood rhabdomyosarcoma, Ewing sarcoma and metastatic, nonseminomatous testicular cancer.

Does Dactinomycin cause hair loss?

Since the growth of normal body cells may also be affected by dactinomycin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.

How does actinomycin D affect protein synthesis?

Actinomycin D (2) acts as a transcription inhibitor, binding to DNA duplexes at the transcription initiation complex and preventing RNA polymerase elongation.

How does actinomycin D inhibit protein synthesis?

Actinomycin D (ActD), is an anti-neoplastic agent that inhibits RNA synthesis by binding to guanine residues and inhibiting DNA-dependent RNA polymerase [15,16].

Who makes Cosmegen?

COSMEGEN is a sterile lyophilized powder and is supplied in vials containing 0.5 mg (500 micrograms) of dactinomycin and 20.0 mg of mannitol. In the dry form the compound is an amorphous yellow powder. The solution is clear and gold-colored. ®Trademark of Recordati Rare Diseases Canada Inc.

Which of the following is in actinomycin?

Actinomycin was first isolated from Streptomyces antibioticus and is produced by many Streptomyces strains. The actinomycins are a family of bicyclic chromopeptide lactones sharing the chromophoric phenoxazinone dicarboxylic acid to which are attached two pentapeptide lactones of nonribosomal origin.

How does actinomycin D bind to DNA?

Actinomycin D (ActD) (Figure 1) is a potent anticancer drug. ActD binds to DNA by intercalating its phenoxazone ring at a GpC step such that the two cyclic pentapeptides of the drug are located in the DNA minor groove (1,2).